Over 68 weeks, people taking semaglutide lost an average of 14.9% of their body weight, with 50.5% of participants losing 15% or more. If…

Compounded tirzepatide costs between $349 and $699 per month as of 2026, which is 67-80% less expensive than brand-name Mounjaro or Zepbound ($1,069/month), making…

China’s Supreme People’s Court upholds Novo Nordisk’s semaglutide compound patent, supporting IP protection.

California’s Medi-Cal will stop covering GLP-1 weight-loss drugs for weight-loss-only prescriptions, effective Jan. 1, 2026.